COGNITION THERAPEUTICS INC 8-K

What Happened
Cognition Therapeutics, Inc. (CGTX) filed a Form 8-K on June 4, 2026 under Item 7.01 to furnish an investor presentation pursuant to Regulation FD. The presentation was attached as Exhibit 99.1 and is being made available for use in communications with investors, analysts, and other parties.

Key Details

• Form 8-K filed June 4, 2026; disclosure reported under Item 7.01 (Regulation FD).
• Exhibit 99.1: investor presentation furnished to public; Exhibit 104 (cover page interactive data) also included.
• The filing does not include earnings, financial results, or executive changes (no Item 2.02, 5.02 disclosures).

Why It Matters
This filing publicly provides the company’s current investor presentation and ensures Cognition Therapeutics complies with Regulation FD by furnishing material presentation materials to the market. For investors, the presentation is the official, timely source for the company’s messaging to analysts and investors; it may contain strategic, product or corporate updates even though no financial results or personnel changes were reported in this filing.